Skip to main content
OpenTrials
Completed

NCT Number: NCT05147974

The Young Adult Clinic (YAC) Study

The overarching aim of the Young Adult Clinic (YAC) study is to evaluate the DOZE app, a digital, transdiagnostic behavioral sleep medicine and self-management approach in young adult patients (ages 18-25) with chronic pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Insomnia Chronic Pain Dyssomnias Insomnia Due to Medical Condition Mental Disorders Nervous System Diseases Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Sleep Disorders, Intrinsic Sleep Initiation and Maintenance Disorders Sleep Wake Disorders

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Women's College Hospital

Toronto, Ontario, M5S 1B2, Canada

About this study

Sleep, activity, and pain interactions have the potential to impact almost all important protective and regulatory processes in the body. Long-term sleep disruption is associated with increased pain sensitivity, prolonged pain duration, and development of chronic pain. Degree of pain relief can directly impact the quality and disruption of sleep, mood, behavior, social participation, and has a devastating impact on Health Related Quality of Life (HRQL).

Transdiagnostic behavioral sleep medicine and self-management is a behavioral modification approach and is currently a frontline therapy like Cognitive behavioral therapy for insomnia (CBTi) in adults with sleep disorders. However, it is still in early stages of development for adolescent and young adult populations, and less so for youth with co-morbid mental and physical health conditions and chronic pain.

Primary aim: Assess the feasibility of implementing the DOZE app.

Secondary aim:

  • To examine the variance in effectiveness outcomes, including sleep health, pain, and overall Health Related Quality of Life (HRQL).
  • To determine the required sample size for a future definitive trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Young adult patients aged 18 - 25 years old, who have
  • Non-malignant chronic pain lasting more than 3 months, with
  • Clinically assessed as having a sleep disorder
  • English speaking with
  • Access to a mobile phone or a computer with internet access.

Exclusion criteria

  • Patients who require urgent CBT treatment as per their health care provider
  • Patients who have received CBT in the past 3 months
  • Patients participating in other psychological treatments and/or drug trials during the study
  • Patients who have other significant medical conditions- Life threatening (e.g. cancer), neurological conditions (e.g. epilepsy)
  • Patients who have other significant psychiatric conditions-Severe depression or active suicide intent
  • Situations resulting in forced sleep disruption or derangement of sleep schedule such as night shift work > 2 nights per week in the past 3months
  • Pregnancy or breastfeeding.
  • Inability to communicate with health care providers or the research personnel
  • Inability to fill out self-report questionnaires, study materials, or follow instructions.

Treatment and study plan

DOZE app

Behavioral

Complete DOZE app: Delivering Online "ZZZ's with Empirical support (DOZE) app plus a Consensus Sleep Diary (CSD).

The DOZE app, is a web-based app optimized for desktop, smartphone, or tablet use. It is a self-management program for adolescents and young adults with sleep problems. The intervention will be delivered on restricted password-protected applications that will allow tracking of adherence (number of logins to app and website using Google Analytics). Participants will be encouraged to log onto the sleep dairy (via automated alerts) once a day over a 10-week period to complete sleep diary entries, develop and track their goals, and receive sleep health education/tailored sleep health interventions.

1-week pre- and post- intervention, participants will complete a battery of baseline study questionnaires and have the option of using a Geneactiv actigraphy device along with a CSD.

Primary outcomes

  1. Study recruitment/retention

    Time frame: 12 weeks

    Number of Participants recruited/dropping out of study (accrual/dropout rates)

  2. Study compliance to DOZE app intervention/Sleep diary

    Time frame: 10 weeks

    Number of Participants completing/using the DOZE app and completing the sleep diary daily during 10 weeks study intervention

  3. Study DOZE app treatment evaluation

    Time frame: 12 weeks

    Participants' scoring on a 5 point Likert scale pre and post study intervention

  4. Issues and concerns reported via phone calls and emails (Fidelity)

    Time frame: 12 weeks

    Issues and concerns reported while using the intervention tracked by a research assistant, control strategy or outcome measures will be monitored. Can the intervention, and outcome measures be completed as planned or patient not comply with use.

Secondary outcomes

  1. Patient reported improvement in pain

    Time frame: 12 weeks

    Number of Participants reporting Pain Inventory on a brief pain inventory scale of 0 to10.

  2. Patient reported improvement in Health Related Quality Of Life

    Time frame: 12 weeks

    Assessment of pain disability and intensity.PROMIS-29 A 29 item Questionnaire to assets physical, mental and social health and wellbeing.

  3. Patient reported Global Impression of Change

    Time frame: 12 weeks

    Number of Participants reporting an improvement in PGIC in Questionnaire. It comprises 2 scales: PGIC has a 7-point scale depicting a patient's rating of overall improvement (from 1- worse/no change to 7- greatly better/considerable improvement; and a 10-point likert scale rating of efficacy of treatment (where 0- is much better and 10- is much worse).

  4. Patient reported improvement in sleep

    Time frame: 12 weeks

    Adolescent sleep hygiene scale- 28 item self reported questionnaire Never (0%) Once in a while (20%) Sometimes (40%) Quite often (60%) Frequently, but not always (80%) Always (100%)

Sponsors and collaborators

Lead sponsor

Women's College Hospital

Other

Collaborators

  • Toronto Metropolitan University

Registry information

Official study title

Evaluating the Effectiveness of a Self-management Transdiagnostic Cognitive, Behavioral, Circadian Treatment on Patient Centered Outcomes Such as Self-efficacy, Pain Control and Overall Quality of Life in the Young Adult Chronic Pain Population

Acronym: YAC

Important dates

Study start
2023
Primary completion
2025
Study completion
2026
First posted
Dec 7, 2021
Registry last updated
Apr 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.